LakeShore Biopharma Co., Ltd
LakeShore Biopharma Co., Ltd (LSB) Revenue
Annual & quarterly revenue history · segment & region breakdown
LSB · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsLakeShore Biopharma Co., Ltd trailing twelve-month (TTM) revenue is $0.58B, an increase of 7.24% year-over-year from $0.61B in FY2025.
Revenue trend
2025 – 2021 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-03-31 | $0.61B | +$0.04B | +7.24% |
| 2024-03-31 | $0.57B | -$0.11B | -16.56% |
| 2023-03-31 | $0.69B | +$0.18B | +36.63% |
| 2022-03-31 | $0.50B | +$0.25B | +95.69% |
| 2021-03-31 | $0.26B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income LakeShore Biopharma Co., Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
LakeShore Biopharma Co., Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CNY.
Data sourced from LakeShore Biopharma Co., Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LSB revenue · 4 questionsLSB's trailing twelve-month (TTM) revenue is $0.58B. That is an increase of 7.24% year-over-year from $0.61B in FY2025.
▸ Source: FMP · LakeShore Biopharma Co., Ltd SEC filings · GAAP · LakeShore Biopharma Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026